These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10919579)

  • 1. Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression.
    Peduto G; Rinsch C; Schneider BL; Rolland E; Aebischer P
    Transplantation; 2000 Jul; 70(1):78-85. PubMed ID: 10919579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression.
    Murua A; Orive G; Hernández RM; Pedraz JL
    J Control Release; 2009 Aug; 137(3):174-8. PubMed ID: 19376171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing host acceptance to encapsulated xenogeneic myoblasts.
    Rinsch C; Peduto G; Schneider BL; Aebischer P
    Transplantation; 2001 Feb; 71(3):345-51. PubMed ID: 11233892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenogeneic delivery of therapeutic products using transient immunosuppression.
    Park K
    J Control Release; 2009 Aug; 137(3):173. PubMed ID: 19520124
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody.
    Mckenzie AW; Georgiou HM; Zhan Y; Brady JL; Lew AM
    Cell Transplant; 2001; 10(2):183-93. PubMed ID: 11332633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-immunomodulating myoblast cell line for erythropoietin delivery.
    Schneider BL; Peduto G; Aebischer P
    Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions.
    Schwenter F; Schneider BL; Pralong WF; Déglon N; Aebischer P
    Hum Gene Ther; 2004 Jul; 15(7):669-80. PubMed ID: 15242527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy.
    Aoki T; Umehara Y; Ferraresso C; Sugiyama N; Middleton Y; Avital I; Inderbitzin D; Demetriou AA; Rozga J
    Cell Transplant; 2002; 11(6):553-61. PubMed ID: 12428745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor.
    Springer ML; Hortelano G; Bouley DM; Wong J; Kraft PE; Blau HM
    J Gene Med; 2000; 2(4):279-88. PubMed ID: 10953919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.
    Güttinger M; Padrun V; Pralong WF; Boison D
    Exp Neurol; 2005 May; 193(1):53-64. PubMed ID: 15817264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation.
    Nagata H; Ito M; Cai J; Edge AS; Platt JL; Fox IJ
    Gastroenterology; 2003 Feb; 124(2):422-31. PubMed ID: 12557148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.
    Mai G; Nguyen TH; Morel P; Mei J; Andres A; Bosco D; Baertschiger R; Toso C; Berney T; Majno P; Mentha G; Trono D; Buhler LH
    Xenotransplantation; 2005 Nov; 12(6):457-64. PubMed ID: 16202069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery.
    Schneider BL; Schwenter F; Pralong WF; Aebischer P
    Mol Ther; 2003 Apr; 7(4):506-14. PubMed ID: 12727114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
    Deuse T; Seifert M; Phillips N; Fire A; Tyan D; Kay M; Tsao PS; Hua X; Velden J; Eiermann T; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
    Circulation; 2011 Sep; 124(11 Suppl):S3-9. PubMed ID: 21911816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules.
    Orive G; De Castro M; Ponce S; Hernández RM; Gascón AR; Bosch M; Alberch J; Pedraz JL
    Mol Ther; 2005 Aug; 12(2):283-9. PubMed ID: 15935736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for fusion between cardiac and skeletal muscle cells.
    Reinecke H; Minami E; Poppa V; Murry CE
    Circ Res; 2004 Apr; 94(6):e56-60. PubMed ID: 15001531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats.
    Vriens PW; Stoot JH; van der Steenhoven TJ; Hoyt G; Bouwman E; Robbins RC
    Xenotransplantation; 2005 Jan; 12(1):63-71. PubMed ID: 15598275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.